ESPE Abstracts

ESPE Abstracts

Published by BioScientifica
Previous issue | Volume 86 | ESPE2016 | Next issue

55th Annual ESPE (ESPE 2016)

Paris, France
10 Sept 2016 - 12 Sept 2016

Card image cap
Paris, France: 10-12 September 2016 Further information

Free Communications

Management of Disorders of Insulin Secretion

Previous section
Pathophysiology of Obesity
Table of contents
Next section
Syndromes: Mechanisms and Management

hrp0086fc5.1 | Management of Disorders of Insulin Secretion

The Anti-diabetic Drug, Metformin, Suppresses Adipogenesis through both AMP-activated Protein Kinase (AMPK)-dependent and AMPK-independent Mechanisms

hrp0086fc5.2 | Management of Disorders of Insulin Secretion

Diabetes and Insulin Injection Modalities: Effects on Hepatic Expression and Activity of 11β-Hydroxysteroid Dehydrogenase Type 1 in Juvenile Diabetic Rats

hrp0086fc5.3 | Management of Disorders of Insulin Secretion

Glibentek, a New Suspension of Glibenclamide for Patients with Neonatal Diabetes, is as Effective and more Convenient than Crushed Tablets

hrp0086fc5.4 | Management of Disorders of Insulin Secretion

Persistent Beneficial Metabolic Effect after Five Years in a Cohort of 28 Subjects with Neonatal Diabetes owing to Potassium Channel Mutation and Transferred from Insulin to Sulfonylureas

hrp0086fc5.5 | Management of Disorders of Insulin Secretion

DPP-4 Inhibitor is an Alternative Effective Treatment in a Common Cause of Anti-GAD Negative “Type 1 Diabetes” - A Founder CISD2 Mutation

hrp0086fc5.6 | Management of Disorders of Insulin Secretion

Impact of Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections on Bone Health in Children and Adolescents with Type 1 Diabetes

Published by BioScientifica

ESPE Abstracts

© Bioscientifica 2025 | Privacy policy | Cookie settings

BiosciAbstracts

Bioscientifica Abstracts is the gateway to a series of products that provide a permanent, citable record of abstracts for biomedical and life science conferences.

Find out more